---

Highlights of September 2021

1. Zydus Cadila inks deal with Shilpa Medicare for ZyCoV-D COVID-19 vaccine production.
2. Serum Life Sciences to invest £50 M in Oxford Biomedica.
3. Lupin gets license to manufacture new TB drug.
4. Dr Reddy’s to sell its rights of anti-cancer agent to Citius Pharma.
5. Biocon Biologics and Serum Institute Life Sciences enter strategic alliance to produce Vaccines.
6. JRF Global and SIRO Clinpharm join hands to offer end-to-end drug development solution.
7. Novartis acquires Arctos Medical, expanding optogenetics portfolio to bring gene therapies to patients with severe vision loss.
8. Mirum out-licenses Maralixibat to Takeda in Japan.
9. Boehringer acquires Abexxa Biologics to expand I-O research.
10. Twist Bioscience signs discovery collaboration with Boehringer.
11. Precision BioSciences and Tiziana Life Sciences partner for Foralumab.